UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

Cancer Immunology, Immunotherapy, 2019-10, Vol.68 (10), p.1681-1688

2019

Volltextzugriff (PDF)

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001962

2021

Volltextzugriff (PDF)

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

Cancer immunology research, 2015-05, Vol.3 (5), p.495-505

2015

Volltextzugriff (PDF)

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma

Oncoimmunology, 2020-01, Vol.9 (1), p.1708066-1708066

2020

Volltextzugriff (PDF)

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials

Clinical cancer research, 2017-10, Vol.23 (19), p.5679-5686

2017

Volltextzugriff (PDF)

High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer

Cancer immunology research, 2015-01, Vol.3 (1), p.48-58

2015

Volltextzugriff (PDF)

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

Cancer Immunology, Immunotherapy, 2019-06, Vol.68 (6), p.1025-1035

2019

Volltextzugriff (PDF)

Recent developments and future challenges in immune checkpoint inhibitory cancer treatment

Current opinion in oncology, 2015-11, Vol.27 (6), p.482-488

2015

Volltextzugriff (PDF)

Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence

Cancer immunology research, 2017-11, Vol.5 (11), p.969-977

2017

Volltextzugriff (PDF)

Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

Cancer Immunology, Immunotherapy, 2019-06, Vol.68 (6), p.1037-1037

2019

Volltextzugriff (PDF)

Abstract 4692: Local adjuvant treatment of clinical stage I-II melanoma with low dose CpG-B and/or GM-CSF: Long-term follow-up of three randomized controlled phase II trials

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4692-4692

2017

Volltextzugriff (PDF)

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation

Science immunology, 2022-07, Vol.7 (73)

2022

Volltextzugriff (PDF)

Abstract B138: Single low-dose administration of anti-CTLA-4/tremelimumab at the tumor excision site boosts systemic antitumor immunity in early-stage melanoma patients: Results from a Phase-1 study

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B138-B138

2016

Volltextzugriff (PDF)

Abstract A050: Local administration of CpG-B increases recurrence-free survival in early-stage melanoma patients: Long-term follow-up of two randomized clinical trials evaluating adjuvant treatment

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.A050-A050

2016

Volltextzugriff (PDF)

Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes

Blood, 2012-05, Vol.119 (20), p.4809-4810

2012

Volltextzugriff (PDF)

Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P201-P201, Article P201

2015

Volltextzugriff (PDF)

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread

Journal for immunotherapy of cancer, 2013-11, Vol.1 (Suppl 1), p.P92-P92

2013

Volltextzugriff (PDF)

N-type organic thermoelectrics: demonstration of ZT > 0.3

Nature communications, 2020-11, Vol.11 (1), p.5694-5694, Article 5694

2020

Volltextzugriff (PDF)

Maternal Cardiovascular Risk Profile After Placental Abruption

Hypertension (Dallas, Tex. 1979), 2013-06, Vol.61 (6), p.1297-1301

2013

Volltextzugriff (PDF)

[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules

Molecular imaging and biology, 2023-06, Vol.25 (3), p.483-494

2023

Volltextzugriff (PDF)

C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study

Journal of hypertension, 2014-02, Vol.32 (2), p.408-414

2014

Volltextzugriff (PDF)

Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy

Heart (British Cardiac Society), 2019-02, Vol.105 (4), p.330-336

2019

Volltextzugriff (PDF)

Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study

Research and practice in thrombosis and haemostasis, 2022-08, Vol.6 (6), p.e12809-n/a, Article e12809

2022

Volltextzugriff (PDF)

LePLDβ1 activation and relocalization in suspension‐cultured tomato cells treated with xylanase

The Plant journal : for cell and molecular biology, 2006-02, Vol.45 (3), p.358-368

2006

Volltextzugriff (PDF)

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer

Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.P211-P211, Article P211

2014

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)
Buchkapitel
(2)

Sprache

Englisch
(27)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma

Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials

High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer

Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

Recent developments and future challenges in immune checkpoint inhibitory cancer treatment

Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence

Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial

Abstract 4692: Local adjuvant treatment of clinical stage I-II melanoma with low dose CpG-B and/or GM-CSF: Long-term follow-up of three randomized controlled phase II trials

Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation

Abstract B138: Single low-dose administration of anti-CTLA-4/tremelimumab at the tumor excision site boosts systemic antitumor immunity in early-stage melanoma patients: Results from a Phase-1 study

Abstract A050: Local administration of CpG-B increases recurrence-free survival in early-stage melanoma patients: Long-term follow-up of two randomized clinical trials evaluating adjuvant treatment

Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes

Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread

N-type organic thermoelectrics: demonstration of ZT > 0.3

Maternal Cardiovascular Risk Profile After Placental Abruption

[18F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules

C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study

Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy

Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study

LePLDβ1 activation and relocalization in suspension‐cultured tomato cells treated with xylanase

Evidence for a coordinate role of CD14+ antigen-presenting cells and regulatory T cells in conditioning the microenvironment of metastatic lymph nodes from patients with cervical cancer

Suchergebnisse filtern